Holdings

Cormorant Asset Management, LP

As of Sep 30, 2026, Cormorant Asset Management, LP reported 54 positions worth US$1.42B. Largest: Parabilis Medicines, Inc., Praxis Precision Medicines, Inc. and Rapport Therapeutics, Inc. What it bought and sold, with each filing.

CompanySharesValue as reportedChangeAs of
Parabilis Medicines, Inc.4.62MUS$149Mno changeSep 30, 2026
Praxis Precision Medicines, Inc.500KUS$146M−140KSep 30, 2026
Rapport Therapeutics, Inc.2.46MUS$82.6M−200KSep 30, 2026
Edgewise Therapeutics, Inc.1.86MUS$75.5M−650KSep 30, 2026
BridgeBio Oncology Therapeutics, Inc.17.9MUS$73.3Mno changeSep 30, 2026
Erasca, Inc.5MUS$73.3M−1MSep 30, 2026
BlossomHill Therapeutics, Inc.3.61MUS$67.4MnewSep 30, 2026
Adlai Nortye Group Ltd.3.98MUS$63.7MnewSep 30, 2026
Dianthus Therapeutics, Inc.500KUS$44M−250KSep 30, 2026
Abivax SA425KUS$42.1M−250KSep 30, 2026